CC
ITCI

Cipher Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Cipher Capital’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$220K Buy
+3,179
New +$218K 0.1% 352
2022
Q4 		– Sell
-5,308
Closed -$247K – 670
2022
Q3 		$247K Buy
+5,308
New +$277K 0.04% 354

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cipher Capital's ITCI Position: Q1 2024 in Review

Cipher Capital opened a new position in Intra-Cellular Therapies Inc. (ITCI) in Q1 2024: 3,179 shares worth $220K. The stake represents 0.1% of the portfolio and ranks #352 among its holdings. This is a return to the name: Cipher Capital previously reported a position in ITCI as recently as Q3 2022.

Cipher Capital first reported a position in ITCI in Q3 2022 and has held it in 2 quarters since. The position peaked at $247K in Q3 2022. 346 funds tracked by Wall St. Rank hold ITCI as of Q1 2024.

  • Cipher Capital held 3,179 shares of Intra-Cellular Therapies Inc. worth $220K as of Q1 2024.
  • Intra-Cellular Therapies Inc. was a new Cipher Capital position in Q1 2024.
  • Intra-Cellular Therapies Inc. made up 0.1% of Cipher Capital's portfolio in Q1 2024, its #352 holding.
  • Cipher Capital first reported a position in Intra-Cellular Therapies Inc. in Q3 2022 and has held it in 2 quarters since.
  • Cipher Capital's Intra-Cellular Therapies Inc. position peaked at $247K in Q3 2022.
  • 346 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.